ADVANCED PHARMACOLOGY FINAL EXAM (UTA)
EXAMINATION COMPLETE QUESTIONS AND
DETAILED SOLUTIONS LATEST UPDATE THIS YEAR
JUST RELEASED
Tested Content Areas (Short Summary)
1. Pharmacokinetics
o Drug absorption, distribution, metabolism, excretion, bioavailability, and half-life
calculations.
2. Pharmacodynamics
o Drug mechanisms of action, receptor interactions, agonists, antagonists, potency, and
efficacy.
3. Autonomic Nervous System Pharmacology
o Adrenergic and cholinergic medications, therapeutic uses, contraindications, and
adverse effects.
4. Cardiovascular Pharmacology
o Antihypertensives, antiarrhythmics, anticoagulants, lipid-lowering drugs, and heart
failure medications.
5. Endocrine Pharmacology
o Diabetes medications, thyroid drugs, corticosteroids, and hormone replacement
therapies.
6. Antimicrobial Pharmacology
o Antibiotics, antivirals, antifungals, resistance mechanisms, spectrum of activity, and
stewardship.
7. Central Nervous System Pharmacology
o Antidepressants, antipsychotics, anxiolytics, anticonvulsants, opioid analgesics, and
anesthetics.
8. Drug Safety and Patient Education
o Adverse drug reactions, black box warnings, medication reconciliation, and patient
counseling.
9. Special Populations
o Pediatric, geriatric, pregnancy, renal impairment, and hepatic impairment medication
adjustments.
10. Evidence-Based Prescribing
Clinical guidelines, drug interactions, therapeutic monitoring, laboratory interpretation, and
individualized treatment.
,Advanced Pharmacology Final Exam (UTA)
1.
Which pharmacokinetic process primarily determines how rapidly an orally
administered medication reaches systemic circulation after gastrointestinal
administration?
A. Drug metabolism
B. Drug absorption
C. Drug elimination
D. Drug excretion
Answer: B
Rationale: Absorption determines the rate and extent that a drug enters systemic
circulation following administration.
2.
A medication with a very high first-pass hepatic metabolism generally
demonstrates which important pharmacologic characteristic after oral
administration?
A. Increased bioavailability
B. Decreased clearance
C. Reduced bioavailability
D. Prolonged half-life
Answer: C
Rationale: Extensive first-pass metabolism significantly decreases the amount of
active drug reaching systemic circulation.
,3.
Which receptor type produces increased heart rate and myocardial contractility
when stimulated by endogenous catecholamines during sympathetic nervous
system activation?
A. Alpha-1 receptors
B. Beta-1 receptors
C. Beta-2 receptors
D. Muscarinic receptors
Answer: B
Rationale: Beta-1 receptor stimulation increases heart rate, contractility, and
cardiac output.
4.
A patient receiving lisinopril develops a persistent dry cough despite excellent
blood pressure control. Which mechanism best explains this adverse effect?
A. Increased dopamine production
B. Bradykinin accumulation
C. Reduced aldosterone secretion
D. Enhanced norepinephrine release
Answer: B
Rationale: ACE inhibition increases bradykinin levels, producing the characteristic
dry cough.
, 5.
Which laboratory value requires the closest monitoring before administering
intravenous unfractionated heparin to prevent excessive anticoagulation
complications?
A. Hemoglobin A1C
B. Activated partial thromboplastin time
C. Serum sodium
D. Troponin level
Answer: B
Rationale: aPTT evaluates therapeutic anticoagulation during unfractionated
heparin therapy.
6.
Which pharmacodynamic principle describes the maximum therapeutic response
a medication can produce regardless of additional dose increases?
A. Potency
B. Bioavailability
C. Efficacy
D. Clearance
Answer: C
Rationale: Efficacy refers to the greatest achievable therapeutic effect.
EXAMINATION COMPLETE QUESTIONS AND
DETAILED SOLUTIONS LATEST UPDATE THIS YEAR
JUST RELEASED
Tested Content Areas (Short Summary)
1. Pharmacokinetics
o Drug absorption, distribution, metabolism, excretion, bioavailability, and half-life
calculations.
2. Pharmacodynamics
o Drug mechanisms of action, receptor interactions, agonists, antagonists, potency, and
efficacy.
3. Autonomic Nervous System Pharmacology
o Adrenergic and cholinergic medications, therapeutic uses, contraindications, and
adverse effects.
4. Cardiovascular Pharmacology
o Antihypertensives, antiarrhythmics, anticoagulants, lipid-lowering drugs, and heart
failure medications.
5. Endocrine Pharmacology
o Diabetes medications, thyroid drugs, corticosteroids, and hormone replacement
therapies.
6. Antimicrobial Pharmacology
o Antibiotics, antivirals, antifungals, resistance mechanisms, spectrum of activity, and
stewardship.
7. Central Nervous System Pharmacology
o Antidepressants, antipsychotics, anxiolytics, anticonvulsants, opioid analgesics, and
anesthetics.
8. Drug Safety and Patient Education
o Adverse drug reactions, black box warnings, medication reconciliation, and patient
counseling.
9. Special Populations
o Pediatric, geriatric, pregnancy, renal impairment, and hepatic impairment medication
adjustments.
10. Evidence-Based Prescribing
Clinical guidelines, drug interactions, therapeutic monitoring, laboratory interpretation, and
individualized treatment.
,Advanced Pharmacology Final Exam (UTA)
1.
Which pharmacokinetic process primarily determines how rapidly an orally
administered medication reaches systemic circulation after gastrointestinal
administration?
A. Drug metabolism
B. Drug absorption
C. Drug elimination
D. Drug excretion
Answer: B
Rationale: Absorption determines the rate and extent that a drug enters systemic
circulation following administration.
2.
A medication with a very high first-pass hepatic metabolism generally
demonstrates which important pharmacologic characteristic after oral
administration?
A. Increased bioavailability
B. Decreased clearance
C. Reduced bioavailability
D. Prolonged half-life
Answer: C
Rationale: Extensive first-pass metabolism significantly decreases the amount of
active drug reaching systemic circulation.
,3.
Which receptor type produces increased heart rate and myocardial contractility
when stimulated by endogenous catecholamines during sympathetic nervous
system activation?
A. Alpha-1 receptors
B. Beta-1 receptors
C. Beta-2 receptors
D. Muscarinic receptors
Answer: B
Rationale: Beta-1 receptor stimulation increases heart rate, contractility, and
cardiac output.
4.
A patient receiving lisinopril develops a persistent dry cough despite excellent
blood pressure control. Which mechanism best explains this adverse effect?
A. Increased dopamine production
B. Bradykinin accumulation
C. Reduced aldosterone secretion
D. Enhanced norepinephrine release
Answer: B
Rationale: ACE inhibition increases bradykinin levels, producing the characteristic
dry cough.
, 5.
Which laboratory value requires the closest monitoring before administering
intravenous unfractionated heparin to prevent excessive anticoagulation
complications?
A. Hemoglobin A1C
B. Activated partial thromboplastin time
C. Serum sodium
D. Troponin level
Answer: B
Rationale: aPTT evaluates therapeutic anticoagulation during unfractionated
heparin therapy.
6.
Which pharmacodynamic principle describes the maximum therapeutic response
a medication can produce regardless of additional dose increases?
A. Potency
B. Bioavailability
C. Efficacy
D. Clearance
Answer: C
Rationale: Efficacy refers to the greatest achievable therapeutic effect.
